Pharmaceuticals
GSK to buy Nuvalent for US$10.6 billion to expand in cancer drugs
The British firm will pay US$124 a share for Nuvalent
J&J to buy cancer drug technology developer Firefly Bio for US$1 billion
JOHNSON & Johnson said on Monday (Jun 8) it will acquire biotech Firefly Bio for US$1 billion in cash, as it looks to expand its cancer drug pipeline.
China’s rise in drug development looms over US
China’s ascendence as a drug development powerhouse could threaten US biotechnology
A GLP-1 tsunami is headed for the vice industry. Good.
A new wave of cheap weight-loss drugs heralds an existential crisis for the sin economy
India’s Sun Pharma to buy US-listed Organon in about US$11.8 billion deal
Sun Pharma will buy all the outstanding shares of Organon for US$14 per share
Competition watchdog seeks public feedback on Zuellig Pharma-Eli Lilly deal
Pact includes Zuellig Pharma getting exclusive rights to make erectile dysfunction drug Cialis in Singapore
Novartis to buy US-based biotech firm Excellergy for up to US$2 billion
The transaction is expected to close in the second half of 2026
Pfizer secures China nod for obesity drug as generics loom
Pfizer now enters a field dominated by multinational rivals
Gilead to buy US biotech Arcellx for up to US$7.8 billion
The US drugmaker seeks to boost its cancer drug pipeline
Walgreens cuts hundreds of jobs after private equity buyout
The pharmacy chain is also slowing down its store closures
